Fredag 7 November | 05:47:13 Europe / Stockholm

Svenska | English

Brain+

Kalender

	Est. tid*
2025-08-28	-	Kvartalsrapport 2025-Q2
2025-06-02	-	X-dag ordinarie utdelning BRAINP 0.00 DKK
2025-05-29	-	Årsstämma
2025-04-29	-	Bokslutskommuniké 2024
2025-02-12	-	Extra Bolagsstämma 2024
2024-08-29	-	Kvartalsrapport 2024-Q2
2024-05-16	-	X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15	-	Årsstämma
2024-05-07	-	Bokslutskommuniké 2023
2023-10-11	-	Extra Bolagsstämma 2023
2023-08-31	-	Kvartalsrapport 2023-Q2
2023-05-30	-	X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26	-	Årsstämma
2023-04-28	-	Bokslutskommuniké 2022
2022-09-29	-	Kvartalsrapport 2022-Q2
2022-09-02	-	Extra Bolagsstämma 2022
2022-05-19	-	X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18	-	Årsstämma
2022-04-29	-	Bokslutskommuniké 2021

Beskrivning

Land	Danmark
Lista	First North Denmark
Sektor	Hälsovård
Industri	Vård & Omsorg

Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.

Filter

År

Typ

Språk

Rensa

2025-11-06 15:13:50 Brain+ investor update — October

2025-10-31 08:00:00 BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE 0,01 DKK | +3,17% | 0,07 MDKK

2025-10-06 08:20:00 Brain+ appoints new Chief Financial Officer 0,01 DKK | -1,54% | 0,02 MDKK

2025-09-24 08:36:00 Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices 0,01 DKK | +4,17% | 0,11 MDKK

2025-09-16 09:21:23 Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla 0,01 DKK | +8,82% | 0,18 MDKK

2025-09-15 11:41:16 The Chief Financial Officer to transition, replacement search has been initiated 0,01 DKK | +9,68% | 0,08 MDKK

2025-09-04 11:58:00 Clinical pilot of Ayla based dementia therapy (CST) improves cognitive outcome by nearly 50% in care home residents 0,01 DKK | +15,79% | 0,20 MDKK

2025-09-02 09:44:00 Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group 0,01 DKK | +1,47% | 0,02 MDKK

2025-09-01 08:41:01 Brain+ invites investors and other stakeholders to a webinar for a presentation of its Half Year 2025 report 0,01 DKK | -1,45% | 0,04 MDKK

2025-08-28 23:23:26 Brain+ publishes Half Year Report for 2025 0,01 DKK | -4,17% | 0,08 MDKK

2025-06-24 14:11:09 Brain+ A/S announces first day of trading in new shares following the TO 5 warrant exercise 0,02 DKK | -1,28% | 0,02 MDKK

2025-06-18 11:22:36 Brain+ A/S announces the outcome of its series TO 5 warrant exercise 0,02 DKK | -1,18% | 0,01 MDKK

2025-06-10 09:58:49 Brain+ A/S has received commitments to cover 100% of its TO 5 warrants, securing DKK 5.9 million in gross proceeds 0,02 DKK | -17,39% | 0,34 MDKK

2025-06-06 16:56:33 Invitation to investor webinar featuring Antony Hall: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla 0,02 DKK | +66,67% | 0,34 MDKK

2025-06-06 10:51:07 New research underscores the effects of Cognitive Stimulation Therapy, supporting its role for UK care homes to comply with care quality statements 0,02 DKK | +66,67% | 0,34 MDKK

2025-06-05 11:49:44 Brain+ signs agreement with UK care home group Majesticare deploying Ayla for effective dementia care

2025-06-02 15:49:53 Brain+ A/S announces the exercise price for its warrants of series TO 5 0,02 DKK | -9,47% | 0,10 MDKK

2025-05-30 16:22:04 Brain+ A/S - Minutes of Annual General Meeting

2025-05-28 08:46:43 Brain+ A/S: Leading UK dementia care authority, Antony Hall, joins Brain+ as Strategic Advisor 0,02 DKK | -2,06% | 0,02 MDKK

2025-05-26 08:48:21 Brain+ A/S: Brain+ signs its second UK sales agreement on Ayla with Park Homes UK Group 0,02 DKK | 0,00% | 0,03 MDKK

2025-05-15 23:27:10 Brain+ A/S convenes the Annual General Meeting for 2025 0,02 DKK | -1,06% | 0,04 MDKK

2025-05-05 09:00:01 Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK 0,02 DKK | +15,56% | 0,08 MDKK

2025-04-29 20:19:45 Brain+ A/S: Brain+ publishes its Annual Report for 2024 0,02 DKK | -4,26% | 0,01 MDKK

2025-04-16 11:15:00 Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO 0,02 DKK | +2,06% | 0,09 MDKK

2025-04-09 08:50:00 Brain+ A/S: Brain+ announces directed issue of units to convertible loan providers and guarantors 0,06 DKK | -7,09% | 0,04 MDKK

2025-04-03 08:41:48 Brain+ A/S: Contract signed with Copenhagen Municipality on extended and expanded access to Ayla 0,05 DKK | +35,00% | 0,30 MDKK

2025-04-02 08:47:12 Brain+ A/S: Brain+ announces outcome of unit rights issue 0,04 DKK | +12,99% | 0,02 MDKK

2025-03-26 08:35:00 Brain+ A/S informs of last day to subscribe in its ongoing rights issue of units 0,04 DKK | -1,68% | 0,01 MDKK

2025-03-25 12:56:36 Brain+ A/S: Brain+ to close first UK Care Home partnership contract with Southcare Homes Group 0,04 DKK | +11,18% | 0,03 MDKK

2025-03-19 14:44:35 Brain+ A/S: Invitation to investor webinar to present new Board Observer, sales pipeline progress and ongoing Unit Rights Issue 0,03 DKK | +10,74% | 0,04 MDKK

2025-03-19 08:42:11 Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators 0,03 DKK | +10,74% | 0,04 MDKK

2025-03-17 08:59:51 Brain+ A/S: The subscription period in Brain+' rights issue of units begins today 0,03 DKK | -10,93% | 0,05 MDKK

2025-03-11 10:54:55 Brain+ A/S: UK care sector expert, Vishal Shah joins Brain+ as Advisor and Board Observer 0,03 DKK | -1,64% | 0,07 MDKK

2025-03-10 08:31:47 Brain+ A/S: The benefits of Ayla - your CST Assistant featured in CareTech, the healthtech media for Danish healthcare professionals 0,03 DKK | +38,01% | 0,27 MDKK

2025-03-06 08:50:19 Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million 0,02 DKK | -31,93% | 0,04 MDKK

2025-02-12 12:02:08 Brain+ A/S - Minutes of Extraordinary General Meeting 0,03 DKK | +6,18% | 0,03 MDKK

2025-01-30 13:47:37 Brain+ A/S: Invitation to Investor Webinar to update on sales outlook, restructuring and secured funding 0,04 DKK | +7,09% | 0,01 MDKK

2025-01-28 18:33:10 Brain+ A/S - Notice of Extraordinary General Meeting 0,04 DKK | -1,25% | 0,02 MDKK

2025-01-22 19:30:00 Brain+ A/S: Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue 0,04 DKK | -17,56% | 0,16 MDKK

2024-12-31 14:30:00 Brain+ A/S: Brain+ announces change of Certified Advisor

2024-12-10 08:45:34 Brain+ A/S: Brain+ invites to investor webinar to update on UK commercial pipeline and status 0,05 DKK | -0,62% | 0,00 MDKK

2024-12-05 08:51:54 Brain+ A/S: Brain+ secures its first multi-year sales contract for Ayla - your CST Assistant with Syddjurs municipality 0,05 DKK | +7,02% | 0,06 MDKK

2024-11-21 15:30:00 Brain+ A/S: Invitation to Investor Webinar on Monday 25th of November at 15:30: Update on commercial status and new opportunities 0,05 DKK | 0,00% | 0,00 MDKK

2024-11-01 11:57:51 Brain+ closes new Danish municipality sales contract on Ayla – your CST Assistant 0,05 DKK | -4,21% | 0,04 MDKK

2024-10-21 11:54:20 Brain+ progresses UK commercial outreach and hosts the first of a series of webinars on the value of Cognitive Stimulation Therapy 0,05 DKK | +0,50% | 0,02 MDKK

2024-10-11 09:04:32 Brain+ unveils new visual brand and website to elevate its Ayla Dementia Care solutions 0,05 DKK | 0,00% | 0,01 MDKK

2024-10-07 11:50:50 Brain+ announces first day of trading in new shares from the TO 4 warrant exercise and the related directed issue 0,04 DKK | 0,00% | 0,02 MDKK

2024-10-02 10:32:09 Brain+ launches Ayla – your CST Assistant into the UK dementia market 0,04 DKK | +9,33% | 0,04 MDKK

Visa fler

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Brain+

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden